Alaska Permanent Fund Banking on Denali IPO
Posted on 11/14/2017
The Alaska Permanent Fund Corporation (APFC), through its finder Crestline Investors, invested in a number of pharmaceutical companies including Juno Therapeutics. APFC invested in several rounds in South San Francisco-based Denali Therapeutics, essentially controlling a 26.5 percent stake in the company. Denali Therapeutics submitted their IPO documents, seeking to raise US$ 100 million in capital […]
- Alaska
- Alaska Permanent Fund Corporation
- Deals
- Denali Therapeutics
- featured
- IPO
- North America
- US
- Venture Capital